Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
U.S. stocks could see a weak opening on Tuesday after the averages registered a mixed last week. While the S&P 500 and Dow Jones snapped their six-week winning streak, the Nasdaq Composite chalked its
Pfizer's earnings crush estimates as company raises guidance
07:23am, Tuesday, 29'th Oct 2024
Drug company Pfizer saw strong growth for its heart-disease drugs and migraine treatment.
Pfizer raises profit forecast after beating third-quarter estimates
06:56am, Tuesday, 29'th Oct 2024
Pfizer raised its full-year profit forecast after better-than-expected sales of its COVID-19 treatment helped it beat Wall Street estimates for third-quarter earnings on Tuesday.
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
06:55am, Tuesday, 29'th Oct 2024
Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales.
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance
06:45am, Tuesday, 29'th Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024 guidance(1) for both Revenues and Adjusted(2) diluted EPS. The
Pfizer, McDonald's Q3 Earnings to Set Early Market Tone; Alphabet, AMD Follow Post-Close
05:00am, Tuesday, 29'th Oct 2024
Pfizer's rebound and McDonald's E. coli impact headline pre-market earnings; post-close focus shifts to Alphabet and AMD.
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
03:09am, Tuesday, 29'th Oct 2024
The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the “Greed” zone on Monday.
Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings?
04:01pm, Monday, 28'th Oct 2024
Pfizer's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the third quarter.
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
01:10pm, Monday, 28'th Oct 2024
Let's look at five pharma and drug companies, PFE, LLY, ABBV, MRK and BMY, that are scheduled to release their third-quarter 2024 results this week.
Will Pfizer Beat Earnings In Q3?
10:23am, Monday, 28'th Oct 2024
Pfizer (NYSE: PFE) is scheduled to report its Q3 2024 results on Tuesday, October 29. We expect the company to post revenue of $15.1 billion and earnings of $0.63 on a per share and adjusted basis, sl
Pfizer management looks to show turnaround as Starboard looms
06:05am, Monday, 28'th Oct 2024
Pfizer's quarterly financial report on Tuesday comes at a critical moment for the U.S. drugmaker and its CEO, as activist hedge fund Starboard Value ramps up the pressure to demonstrate concrete resul
6 High-Yield Dividend Stocks Every Passive Income Investor Should Own in 2024
09:43am, Sunday, 27'th Oct 2024
24/7 Wall St. Insights Interest rates are expected to decline to 3.25% by 2026.
These 7 Blunt Words Just Opened a Can of Worms For Pfizer's Stock
09:15am, Sunday, 27'th Oct 2024
The company's problems are no longer deniable.
3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever
06:48pm, Saturday, 26'th Oct 2024
The market is overlooking the bigger picture for these three names. That means opportunity for you.
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
11:15am, Saturday, 26'th Oct 2024
Knowing these will help you avoid making suboptimal investing decisions.
